Johnson & Johnson on July 30 announced that its lead vaccine candidate protected against infection by SARS-CoV-2, the virus that causes COVID-19, in pre-clinical studies.
vĐồng tin tức tài chính 365
Johnson & Johnson COVID-19 vaccine candidate demonstrates protection in pre-clinical studies
2020-08-04 16:36
Johnson & Johnson on July 30 announced that its lead vaccine candidate protected against infection by SARS-CoV-2, the virus that causes COVID-19, in pre-clinical studies.